Celyad Oncology SA
XBRU:CYAD

Watchlist Manager
Celyad Oncology SA Logo
Celyad Oncology SA
XBRU:CYAD
Watchlist
Price: 0.4745 EUR -5.1%
Market Cap: 19.7m EUR
Have any thoughts about
Celyad Oncology SA?
Write Note

Celyad Oncology SA
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celyad Oncology SA
Pre-Tax Income Peer Comparison

Comparables:
M
MDXH
GLPG
OXUR

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Celyad Oncology SA
XBRU:CYAD
Pre-Tax Income
-€7.8m
CAGR 3-Years
20%
CAGR 5-Years
26%
CAGR 10-Years
N/A
M
MDxHealth SA
NASDAQ:MDXH
Pre-Tax Income
-$59.4m
CAGR 3-Years
-28%
CAGR 5-Years
-14%
CAGR 10-Years
-9%
Galapagos NV
AEX:GLPG
Pre-Tax Income
€58.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Oxurion NV
XBRU:OXUR
Pre-Tax Income
-€19m
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
N/A

See Also

What is Celyad Oncology SA's Pre-Tax Income?
Pre-Tax Income
-7.8m EUR

Based on the financial report for Jun 30, 2024, Celyad Oncology SA's Pre-Tax Income amounts to -7.8m EUR.

What is Celyad Oncology SA's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
26%

Over the last year, the Pre-Tax Income growth was 74%. The average annual Pre-Tax Income growth rates for Celyad Oncology SA have been 20% over the past three years , 26% over the past five years .

Back to Top